Early Reports on the Prognostic Implications and Immunotherapeutic Potentials of Cd34 Rich Cord Whole Blood Transfusion in Advanced Breast Cancer with Severe Anemia
Anemia is the commonest comorbidity, which prevents an aggressive and effective treatment initiation in case of advanced cancer. It increases with the progression of the disease.1 Severe anemia can cause subsequent tumor cell hypoxia, which can reduce the tumorocidal effect of each modality of treatment including radiation.
KeywordsCord Blood Advanced Breast Cancer Umbilical Cord Blood Invasive Lobular Carcinoma Government Hospital
The Department of Science and Technology, Government of West Bengal, supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006. The author gratefully acknowledges the support of the patients who volunteered for this study. The guidance of Prof. K. L. Mukherjee of Biochemistry, and Prof. M. K. Chhetri, the former Director of Health Services, West Bengal, is also acknowledged.
- 2.Mith RE Jr, Tchekmedyian S. Practitioners’practical model for managing cancer elated anemia. Oncology (Huntingt). 2002;16(9 Suppl 10):55-63.Google Scholar
- 4.Tchekmedyian NS. Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Huntingt). 2002;16(9 Suppl 10):17-24.Google Scholar
- 13.Bhattacharya N, Mukherjee KL, Chettri MK, Banerjee T, Mani U, Bhattacharya S. A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. Clin Exp Obstet Gynecol. 2001;28(1):47-52.PubMedGoogle Scholar
- 27.Roitt I, Brostoff J, Male D. Immunology. 6th ed. London, UK: Mosby; 2001:205-206: Chap. 12.Google Scholar
- 31.Migliaccio AR, Alfani E, Di Giacomo V, Cieri M, Migliaccio G. Ex vivo amplification of T cells from human cord blood. Pathol Biol (Paris). 2005;53(3):151-158. Review.Google Scholar